Efficacy and safety of re-induction therapy with bevacizumab and paclitaxel for metastatic breast cancer
Crossref DOI link: https://doi.org/10.1007/s12282-016-0686-3
Published Online: 2016-03-24
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yoshinami, Tetsuhiro
Yagi, Toshinari
Okuno, Jun
Kittaka, Nobuyoshi
Ishitobi, Makoto
Sugimoto, Naotoshi
Nakayama, Takahiro
Tamaki, Yasuhiro
Imamura, Fumio
Text and Data Mining valid from 2016-03-24